BNP and Vascular Surgery (BNPinVasc)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03926104|
Recruitment Status : Recruiting
First Posted : April 24, 2019
Last Update Posted : April 24, 2019
Background and rationale of the study:
Patients undergoing non-cardiac major surgery show a perioperative cardiac risk and postoperative complications, that can be stratified based on parameters linked to patient's conditions and to surgery types.
An accurate identification of this risk could offer numerous advantages for these patients, who's 30-day mortality is around 2%. The identification of the correct risk could lead to a better pre- and postoperative management, that could guarantee a better surgery outcome and a faster postoperative recovery.
To this day there is no perfect method to correctly estimate this risk. Various studies show that high BNP levels are linked to cardiac events at 30 and 180 days. Further investigations identify different groups, at low, intermediate and high risk, based on BNP levels.
BNP is released by ventricular myocytes in response to a wall distress, due to an increased volume, pressure or myocardial ischemia.
So BNP plasma levels could be used as a prognostic and diagnostic marker, improving the cardiac risk stratification in patients undergoing surgery and a much more precise management.
This study is determined to do an evaluation of the correlations between pre- and postoperative BNP levels and the incidence of cardiac events in patients undergoing major vascular surgery.
|Condition or disease|
|General Anesthesia Vascular Surgery Abdominal Aortic Aneurysm Natriuretic Peptide, Brain Mets Preoperative Period Postoperative Period|
Patient's informed consent signature for adhesion at the study will be initially requested. With their acceptance, parameters will be recorded anonymously in the Case Report Form, identified by their initials and a numeric code, until hospital discharge.
The parameters analyzed will be related to:
- preoperative evaluation: anamnesis, health general conditions, METs, preoperative monitoring, in particularly BNP basal levels;
- intraoperative evaluation: intraoperative monitoring;
- postoperative evaluation: BNP and cTnI levels at 24 and 48 hours, and about pulmonary, cardiovascular, neurological and surgical postoperative complications, based on the medical record.
The data will be transferred on Excel worksheet, utilized for descriptive analysis related at every variable.
|Study Type :||Observational|
|Estimated Enrollment :||165 participants|
|Official Title:||Evaluation of BNP Values in Major Vascular Surgery|
|Actual Study Start Date :||December 10, 2018|
|Estimated Primary Completion Date :||December 10, 2020|
|Estimated Study Completion Date :||December 10, 2020|
- Incidence of cardiac events [ Time Frame: from the induction of general anesthesia until hospital discharge, an average of 1 week ]
- Incidence of postoperative pulmonary complication [ Time Frame: from immediately after surgery until hospital discharge, an average of 1 week ]
- Incidence of postoperative neurological complication [ Time Frame: from immediately after surgery until hospital discharge, an average of 1 week ]
- Incidence of postoperative acute kidney failure [ Time Frame: from immediately after surgery until hospital discharge, an average of 1 week ]
- Incidence of unplanned ICU admission [ Time Frame: from immediately after surgery until hospital discharge, an average of 1 week ]
- Hospital length of stay [ Time Frame: from immediately after surgery until hospital discharge, an average of 1 week ]
- Incidence of mortality [ Time Frame: from immediately after surgery until hospital discharge, an average of 1 week ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03926104
|Contact: Elena Giovanna Bignami, MD Professoremail@example.com|
|Elena Giovanna Bignami||Recruiting|
|Parma, Italy, 43126|
|Contact: Elena Giovanna Bignami, MD Professor|